Our Pipeline
Novel small-molecule therapeutics from trillion-molecule screens
validated in disease-specific digital patients
Fully Owned
MYR-001
Cancer & infectious disease
Therapeutic Area:Oncology & Infectious Disease
Target:Undisclosed (myristoylation pathway)
Modality:Small Molecule
StageLead Optimization
DiscoveryApproval
Fully Owned
GLC-001
Glaucoma
Therapeutic Area:Ophthalmology
Target:Undisclosed (trabecular meshwork outflow)
Modality:Small Molecule
StageLead Optimization
DiscoveryApproval
Fully Owned
IMO-001
Solid tumors
Therapeutic Area:Oncology (Immuno-oncology)
Target:Undisclosed (trispecific)
Modality:Small Molecule
StageLead Optimization
DiscoveryApproval
Fully Owned
GPR-001
Inflammatory pain & sickle-cell vaso-occlusive crisis
Therapeutic Area:Inflammation & Hematology
Target:GPR55
Modality:Small Molecule
StageLead Optimization
DiscoveryApproval
Partner With Us
Interested in collaborating on one of our programs or discussing a new therapeutic area?
Schedule a Demo